Results 201 to 210 of about 72,871 (224)

Ritonavir and Lopinavir/Ritonavir

2007
openaire   +1 more source

Ritonavir

Reactions Weekly, 2016
  +4 more sources

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

Lancet, The, 2007
Kiat Ruxrungtham
exaly  

Nirmatrelvir and ritonavir

Clinical Therapeutics
openaire   +2 more sources

Lopinavir/Ritonavir

Drugs, 2012
exaly   +2 more sources

Ritonavir

Reactions Weekly, 2005
openaire   +1 more source

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Lancet, The, 2010
Joseph J Eron, Benjamin Young, Jaime Andrade-Villanueva   +2 more
exaly  

Senescence as a main mechanism of Ritonavir and Ritonavir‐NO action against melanoma

Molecular Carcinogenesis, 2019
Svetlana Paskaš, Tamara Krajnovic, Maria Sofia Basile   +2 more
exaly  

Concentration effect relationship of CYP3A inhibition by ritonavir in humans

European Journal of Clinical Pharmacology, 2013
Marianna Cortese, Antje Blank, Jürgen Burhenne   +2 more
exaly  

Ritonavir

2021
openaire   +1 more source